What Does 4,383 Mean for MSK Authors?

Posted on by

This is the number of works published in 2017 that were added to the MSK publications database, Synapse.  This number (4,383) also represent an increase of 8% from the number of works added in 2016.  Welcome to the 2017 Synapse Publications Report! And feel free to check out our Archive Report page.

Our report highlights subject breadth and depth of works by our many authors. This year we have added a new section to illustrate MSK’s research collaboration by exploring 2017 research papers and all authors’ affiliations.
Synapse is a public facing resource and the authoritative bibliographic database developed and maintained by a skilled team of information professionals. Their ultimate goal is to track the wealth of knowledge attributed to Memorial Sloan Kettering Cancer Center.

I hope that browsing the 2017 Synapse Publications Report you’ll gain a sense of the contributions of our authors to the ever-growing body of scholarly literature. Your thoughts about this report would be welcomed — feel free to send me an email and let me know what you think!

Donna Gibson
Director of Library Services

Women with High Body Fat, Normal BMI at Increased Breast Cancer Risk

Posted on by

A new study by MSK’s Dr. Neil Iyengar and colleagues published in JAMA Oncology finds that women with normal BMIs but high levels of overall body fat are at an increased risk for invasive breast cancer. The cohort study followed 3,460 postmenopausal women for a median 16.4 years. Researchers measured body fat using Dual-energy X-ray absorptiometry five times throughout the course of the study. They concluded that for each five kilogram increase in trunk fat, women had a 56% increase in risk of developing estrogen-receptor (ER) positive breast cancers, even when BMI remained in the healthy range.

Learn more about this study:
MediBulletin
MedicalResearch.com
MedPage Today

First Look! The CRISPR Journal

Posted on by

The CRISPR Journal cover

The CRISPR Journal is a new peer-reviewed publication from Mary Ann Liebert started in February of 2018.  The journal delivers groundbreaking multidisciplinary research, advances, and commentary on CRISPR.  Areas of coverage for the journal include:

  • CRISPR biology and technology
  • Host-pathogen interactions
  • Microbial immunity
  • Genetic diseases
  • Gene therapy
  • Cancer immunotherapy
  • Embryonic development
  • Bioinformatics
  • Systems biology
  • CRISPR-Cas evolution
  • Animal models
  • Organ transplantation
  • Bioethics
  • IP and patenting

The CRISPR Journal provides a home for original research papers, as well as review articles, perspectives, profiles, and commentary.  Authors interested in submitting should consult their Information for Authors page.

To learn more about the origins of The CRISPR Journal, please join us for our next Advancing Authorship event on Wednesday, 12/19.